The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CA209-9JC: A phase II study of first-line nivolumab (NIVO) in patients (pts) with locally advanced or metastatic cutaneous squamous cell carcinoma.
 
Rodrigo Ramella Munhoz
Honoraria - Bristol-Myers Squibb; Merck Serono; Merck Serono; MSD; Novartis; Roche; Sanofi
Consulting or Advisory Role - Lilly; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb; Lilly; MSD; Novartis; Roche
Expert Testimony - Lilly
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche; Sanofi
 
Veridiana Pires De Camargo
Honoraria - BMS Brazil; MSD
Speakers' Bureau - BMS Brazil; MSD; Novartis
 
Guilherme N Marta
No Relationships to Disclose
 
Jade Cury Martins
Honoraria - Takeda
Speakers' Bureau - Takeda
 
Mirella Nardo
No Relationships to Disclose
 
Caroline Chaul Barbosa
No Relationships to Disclose
 
Carina Echer de Souza
No Relationships to Disclose
 
Ingrid Barbosa
No Relationships to Disclose
 
Herminia Ricci
No Relationships to Disclose
 
Marcela Rodrigues de Mattos
No Relationships to Disclose
 
Thiago Menezes
No Relationships to Disclose
 
Guilherme Urano Machado
No Relationships to Disclose
 
Eduardo Bertolli
Consulting or Advisory Role - BMS Brazil; MSD Oncology
Speakers' Bureau - BMS Brazil
 
Milton Jose Barros
No Relationships to Disclose
 
Fabio A. Franke
No Relationships to Disclose
 
Olavo Feher
No Relationships to Disclose
 
Gilberto Castro
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche; Teva; Yuhan
Speakers' Bureau - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer; Roche